Complaint
| Product Name | Norfloxacin |
| Synonyms | 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylica; ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylica; am-715;MK-366;NORFLOXACINE;NORFLOXACIN LACTATE;NORFLOXACIN;noroxin |
| CAS | 70458-96-7 |
| MF | C16H18FN3O3 |
| MW | 319.33 |
| EINECS | 274-614-4 |
| Product Categories | Pharmaceutical;Active Pharmaceutical Ingredients;APIs;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Aromatics;Heterocycles;Pharmaceutical intermediates;NOROXIN |
| TEST | SPECIFICATION | RESULT | |
| Description | White to pale yellow,hydroscpion, photosensitive, crystalline powder | Complies | |
| Related Substances | Impurity E | max.0.1% | 0.01% |
| Methyl-Norfloxacin | max.0.15% | 0.08% | |
| Unspecicifed Impurities | max.0.1% | 0.04% | |
| Total Impurities | max.0.5% | 0.2% | |
| Loss on drying | max.1.0% | 0.3% | |
| Residue on ignition | max.0.1% | 0.05% | |
| Heavy metals | max.15ppm | 10ppm | |
| Assay | 99.0%-101.0% | 99.8% | |
